Fenner, Martin
Oing, Christoph
Dieing, Annette
Gauler, Thomas
Oechsle, Karin
Lorch, Anja
Hentrich, Marcus
Kopp, Hans-Georg
Bokemeyer, Carsten
Honecker, Friedemann http://orcid.org/0000-0002-3700-3577
Funding for this research was provided by:
Novartis Pharma
Article History
Received: 13 August 2018
Accepted: 11 September 2018
First Online: 19 September 2018
Compliance with ethical standards
:
: AD: honoraria for speaking at symposia by Novartis. MH: financial support by Novartis for attending symposia. CB: honoraria for speaking at symposia and refunding of travel costs by Novartis. The remaining authors (MF, CO, KO, TG, GK, FH) declare that they have no conflict of interest.
: The RADIT trial was approved by the Ethics Committee of the Hannover Medical School and the institutional review boards of all participating centers. The clinical trial was conducted in accordance with the ethical principles originating from the 1964 Declaration of Helsinki and its later amendments, consistent with Good Clinical Practice (GCP) and the applicable laws and regulations.
: Written informed consent was obtained from all individual participants included in the study.